ClinicalTrials.gg
RecruitingNCT06699199Updated Mar 6, 2025

Effect of Silver Diamine Fluoride Application on Oral Microbiome of Healthy Pediatric Patient

A Phase 4 interventional study of Silver diamine Fluoride 38% and Silver diamine fluoride- potassium iodide in Dental Caries, sponsored by King Abdulaziz University. Recruiting at 1 site in Saudi Arabia. Open to participants aged 4 Years to 12 Years. Per ClinicalTrials.gov, last updated 2025-03-06.

Sponsored by King Abdulaziz University · Phase 4, Interventional, and Prevention

How we know

From the registry’s dates

  • Primary completion was expected by Jun 2025, 1 year 4 months ago, but the record still lists the study as recruiting.
  • Registered 1 year after the study started (first participant enrolled Nov 2023, registered Nov 2024).
  • Started Nov 2023; still recruiting 3 years later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Phase 4
Study type
Interventional
Enrollment
50
Allocation
Randomized
Ages
4 Years to 12 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 15 studies in Dental Caries by King Abdulaziz University — 2 open to participants now, 2 under way, none of them phase 3. Dental Caries · King Abdulaziz University.

Planned enrollment
9th of 15
50 · median 54
Started
2023
with 1 other
Phase 4
4 of 15
1 open now
Registered
12th of 15
by date

Among the 15 studies in Dental Caries by King Abdulaziz University, this one is the 9th largest by planned enrollment, is one of 2 that started in 2023, is one of 4 in phase 4, and was the 12th registered.

Dental Caries

1,176 studies on the registry are indexed under Dental Caries; 209 are open to participants now.

Browse Dental Caries studies →

Open to participants now

2 of the 15 studies in Dental Caries by King Abdulaziz University are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 2 open studies →

Where they have run

Who these studies take

Of the 86 Dental Caries studies recruiting now, 18 (21%) set no upper age limit and 66 (77%) stop at 75 or younger; 60 take children under 18; 53 take healthy volunteers.

This study: 4 Years to 12 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 15 studies in Dental Caries by King Abdulaziz University, or all of them as a file.
02

Study summary

This clinical trial aims to learn more about the working mechanism of an antimicrobial agent used to manage dental caries, especially in young, uncooperative children. It will also provide a deeper insight into different products of the same agent and its effectiveness in Arresting dental caries.

The main questions it aims to answer are:

What is the clinical impact of silver diamine fluoride application in caries-active children? What is the antimicrobial effect of silver diamine fluoride in oral microbial inhabitants? Researchers will compare silver diamine fluoride (SDF)only and silver diamine fluoride+ potassium iodide(SDF+KI) to see which materials substantially affect on dental caries and oral microbial inhabitants

Participants/Parent will:

The parent will fill out a comprehensive data sheet for the child (childhood and current dental and medical history) Visit the dental clinic to Receive one of 2 (SDF or SDF+KI) treatment applications once Visit the clinic a 2nd time for a 2-4 week Treatment Follow-up Go through the sample collection process twice( pre- and 2-4 weeks post- Treatment) Sample collection including (Saliva- Biofilm and caries tissue sample)

Read the detailed description

Aim of the Work

This study aims to:

  1. Evaluate the Arresting effect of 1-step (SDF only) versus 2-step (SDF+KI) application.
  2. Explore the effectiveness of SDF compared to SDF+KI on oral Microbiome.
  3. Evaluate and compare saliva composition before and after SDF application. Study Question What is the clinical and laboratory impact of silver diamine fluoride application in caries-active children? Research Null Hypothesis

<!-- -->

  1. There is no difference in the Arresting effect of SDF versus SDF+KI application.
  2. There is no difference between the effectiveness of SDF versus SDF+KI application on oral Microbiome.
  3. There is no difference in in saliva composition before and after SDF

Research protocol:

Materials and methods The study will be conducted at the Department of Pediatric Dentistry, Faculty of Dentistry, King Abdul Aziz University, after approval from the University Institutional Ethics Committee.Informed consent will be obtained from the participant\'s parent. The sample will be collected, and sent to King Fahd Medical Research Center

Patients' enrollment An informed consent document will be obtained from those participant parents willing to be part of the trial before the study start. A brief interview-based survey will be conducted about general and dental health, oral hygiene, sugar consumption, and family demographics. A calibrated pediatric dentist will do dental examinations and lesion evaluations, followed by sample collection.

Biospecimens collection protocol:

  • All participants will be required to fast for 90 minutes prior to specimen collection.
  • All participants will be seated in an upright position in the dental chair.
  • Sample will be collected in the first visit for all children, and another set of samples will be collected again for children recruited in the second part of the study.
  • Each child will have an oral swab, saliva, supragingival plaque, and subsurface dentine obtained. The collection will be conducted in the following manner:

    1. Saliva sample ▪ Unstimulated saliva (S, Saliva) will be obtained from enrolled children. using a standardized Spitting method

      ▪ Approximately 5 ml of un-stimulated saliva will be collected using 50 ml falcon tube/ specimen container.

      ▪ Collected saliva will transferred and stored in an Eppendorf tube using 5-10 ml syringe.

    2. Biofilm samples

      ▪ Biofilm samples will be collected from both teeth with and without Carious surfaces.

      ▪ Sterilized Microbrush/paper points will be used for collection of dental plaque

    3. Subsurface carious dentin ▪ Sample collection from within the extensive untreated caries (at baseline visit) ▪ Sterilized dental excavators and sterilized large round bur will be used for sample collection▪ Subsurface carious dentin excavation utilizing a spoon excavator and round bur to extract carious dentin tissue (1.0 to 1.5 mm of depth) Collection and storage procedure The sample will be collected from recruited children at the first visit (as the baseline).

A sterilized dental instrument will be used for the collection of samples, The samples will be stored in Eppendorf tubes filled with 200LμL of phosphate-buffered saline (PBS) solution. Before laboratory analysis, all gathered samples will be kept in a freezer at - 80 °C.

Clinical trial PICO:

P: Children aged 2-10 years caries-free or with caries- active (with at least 1 tooth with deep cavitated lesions (with no signs of pulpitis)) I: Management using SDF (Silver diamine fluoride 38%) C: Management using a different fluoride containing product (SDF 38%+KI) O: Alteration in metabolomics and microbiome.

Patients' enrollment At the first visit, children with active dental caries will undergo a sample collection process conducted by a calibrated pediatric dentist who will also provide the intervention treatment during the same session (baseline visit). A second sample collection appointment will be scheduled after two to three weeks, followed by another follow up visit after two-week.

Study groups:

  • Experiment group The intervention participant will receive silver diamine fluoride 38%
  • Comparison group The Comparison participant will receive SDF+KI system. Intervention A calibrated pediatric dentist will perform the procedures. Saliva and plaque sample will be collected on completion of SDF application.

Sample collection:

  • Sample collection will be conducted Before, 2 and 4 weeks after Intervention.
  • The sample included are saliva, supragingival and occlusal plaque, caries plaque (Carious and SDF-treated surfaces), and subsurface carious dentin (from within the carious untreated lesion)▪ Plaque Sample of supragingival and occlusal plaque will be collected from primary and permanent teeth. Outcomes The primary outcome measure will be the difference in microbiome groups over time and the difference within the treatment groups. The secondary outcome will be the effect on salivary metabolomics.

Assessment will include:

  1. The microbial community composition of surface biofilm prior to and post SDF treatment.
  1. Subsurface microbiota and microbial community composition prior and post SDF treatment.
  1. Comparing the microbial community composition of dentin\&amp;amp;#39;s subsurface microbiota after treatment with SDF and SDF+KI. 4. Salivary metabolomics before and after SDF Statistical Analyses Continuous data will be reported as means and standard deviations, whereas categorical variables will be presented as frequencies and percentages (SD). Statistical significance across groups will be determined using either a one-way analysis of variance (ANOVA) model or the non-parametric version of the Kruskal-Wallis test, depending on whether the variables are normally distributed. Using R, taxonomy plots and tables will be generated, and relative abundance at different taxonomic levels and microbial diversity indices will be calculated. Between the groups, relative abundance and alpha and beta diversity parameters will be evaluated. In addition, the relationship between caries activity, caries risk factors, clinical features, and microbiota composition will be studied prior to and following intervention. Statistical significance will be regarded when p-values are less than 0.05, and P-values in multiple comparisons will be adjusted for the false discovery rate (FDR). Expected Findings:1. There is a difference in the clinical and microbial effect of SDF versus SDF+KI application on oral microbiome 2. There is a shift in saliva composition before and after SDF.
03

Conditions studied

  • Dental Caries

Browse trials for

Keywords

  • Dental Management
  • Oral Microbiome
  • Caries Arrest
  • SDF
  • Silver diamine fluoride 38%
  • Potassium iodide
04

Who can participate

Ages eligible
4 Years to 12 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Healthy patients.
  • Patients within 4-10 years of age.
  • The presence of at least one deciduous tooth with a caries lesion that is directly accessible (cavitates)

Exclusion criteria

Exclusion Criteria:

  • Presentation of irreversible pulpititis or necrosis• The extensive lesion was restored.
  • The surface of the lesion was hard and smooth.
  • Children with inherited or systemic conditions.
  • Children with a substantial medication history or those who have taken antibiotics within the previous three months.
  • Children who have undergone topical fluoride treatment within the previous 2 weeks.
05

Study design

Phase
Phase 4
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
50 participants (estimated)

Study arms

  • Active comparator
    Arresting Treatment 1

    Management of dental caries in children between the ages of 4 and 10 by arresting the lesion using standard Treatment for caries arrest, which is silver diamine fluoride %38

    Drug: Silver diamine Fluoride 38%

  • Experimental
    Arresting Treatment 2

    Management of dental caries n children between the ages of 4 and 10 by arresting the lesion using an alternative Treatment by using the combination of Silver diamine fluoride 38% + potassium iodide (SDF+KI), Both products reported as materials with an anti-microbial effect

    Drug: Silver diamine fluoride- potassium iodide

Interventions

  • DrugSilver diamine fluorideStudies of Silver diamine fluorideSilver diamine fluoride pageHow we knowJudged by ClinicalTrials.gg, not part of the registry record.

    Intervention is the application of Silver diamine fluoride 38% to children Group in arm 1 (Arm 1): children will receive Silver diamine fluoride 38% application for 1 min to arrest primary teeth SDF: (Silver diamine fluoride 38% is a material used for arresting caries lesions in primary and permanent teeth) - SDF Product generic name and information (E-SDF: it is a 1-step Technique) - The 38% SDF solution comprised a blend of silver, fluoride, and ammonia at a total concentration of 38%.

    Also known as: E-SDF, Silver diamine fluoride

  • DrugSilver diamine fluoride- potassium iodide

    Intervention is the application of Silver diamine fluoride 38% + potassium iodide to children Group in arm 2 (Arm 2): children will receive Silver diamine fluoride 38% application for 1 min to arrest primary teeth, Followed by an second minute of potassium iodide solution application - SDF Product generic name and information (Riva-star: it is a 2-step Technique) 30-35% SDF solution (1st step) comprised a blend of silver, fluoride, and ammonia applied in combination with a second application of potassium iodide solution (2nd step)

    Also known as: Silver diamine fluoride 38% + potassium iodide, Riva- star SDF

06

What researchers measure

Primary outcomes

  1. Arresting Effect

    Arresting conditions (Arresting rate) will be assessed through clinical examination and intra-oral Photos evaluation of the cavities before and 2-4 weeks after SDF treatments * Caries activity status will be recorded as (active;1 or arrested;2) according to hardness and color (Caries activity status scored as 1: active or 2: arrested * Descriptive definition : * 1:Active lesion: tooth surface is deemed active if any softened area on the carious lesion is detected upon probing or no obvious changes in color, and the lesion is still soft. * 2:Arrested lesion: When the entire carious lesion is determined to be hard upon probing, or lesion is Darker in color and has hard surfaces (harder to excavate with a spoon excavator), it will be recorded as arrested caries.

    Time frame: Baseline and follow up (after 2-4 weeks)

Secondary outcomes

  1. Microbial status

    Change in oral Microbial inhabits using sequencing techniques of the oral Microbiome. Microbial DNA will be extracted and sequenced using 16S rRNA gene amplicon-based and shotgun metagenomic sequences. Data will be presented as 1. Changes of microbial taxonomic profiles and microbial diversity within the same group (SDF group or SDF+KI group) 2. Difference in microbial taxonomic profiles and microbial diversity between interventions groups after assigned treatment application, differences between groups (SDF group and SDF+KI group)

    Time frame: Baseline and follow up (after 2-4 weeks)

Other outcomes

  1. Adverse events

    Any reported outcome by the child or parents of the following; (by answering a yes or no questions in a follow up visit short interview based questionnaire) * Pain/ sensitivity: (Yes or No) * Discoloration/stains other areas (Extra- Intra):(Yes or No) * Metallic taste: (Yes or No) * Gingival lesions: (Yes or No) * Pulp or abscess: (Yes or No)

    Time frame: Baseline and follow up (after 2-4 weeks)

07

Study locations

1 of 1 sites recruiting
  • University Dental hospital of King Abdulaziz University
    Jeddah, Makkah Province 80209, Saudi Arabia
    Recruiting
    • Dr.Nada O Bamashmous ( Head of Pediatric Dentistry Department), BDS, MSc, DDENT · Contactnobamashmous@kau.edu.sa · + 966 506356401
    • Prof. (Dr.) Abdullah S AlMushayt (Postgraduate Programs Director), BDS, MSc, PhD · Contactaalmushayt@kau.edu.sa · +‭00966507733313‬
    • Dr.Doaa Y Jamal (PhD candidate), BDS, MSc, SBPD · Principal investigator
    • Dr. Turki S Abujamel, BDS, MSc, PhD · Principal investigator
08

References and documents

Individual participant data

Plan to share: Undecided — The quantity of patient data to be provided has not yet been determined. Prior to confirming any plans for sharing patient information, the Organisation will thoroughly assess and approve the data sharing process to guarantee compliance with patient confidentiality rights.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Nov 2023 (actual). Primary completion is estimated for Jun 2025, 19 months after the start.

Of 25 phase 4 interventional studies under Dental Caries, half reached primary completion within 19 months of starting (the median), counting those still running; a quarter within 13 and three quarters within 31. This study's planned 19 months is close to that.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 9, 2024
First posted
Nov 21, 2024
StartActual
Nov 1, 2023
Primary completionEst.
Jun 30, 2025
CompletionEst.
Jun 30, 2025
Last update
Mar 6, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 6, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06699199
Lead sponsor
King Abdulaziz University
Collaborators
King Fahd Medical Research Centre
Responsible party
Doaa Yasir Jamal (PhD candidate - Pediatric dental specialist, King Abdulaziz University) — Principal investigator
First posted
Nov 21, 2024
Start date
Nov 1, 2023
Primary completion
Jun 30, 2025 (estimated)
Completion
Jun 30, 2025 (estimated)
Last update
Mar 6, 2025

Study contacts

Dr.Doaa Y Jamal, BDS, MSc, SBPD
Contact
Djamal0004@stu.kau.edu.sa
(+966)-558887632
Prof. (Dr.) Abdullah S AlMushayt, BDS, MSc, PhD
Contact
aalmushayt@kau.edu.sa
(+966)-507733313
Dr. Turki S Abujamel, BDS, MSc, PhD
study director · Department of Medical Laboratory Science, King Abdulaziz University and KFMRC Deputy Director of Administrative and Financial Affairs.
Prof. (Dr.) Abdullah S AlMushayt, BDS, MSc, PhD
study director · Faculty of Dentistry, Department of Pediatric Dentistry, King Abdulaziz University Jeddah, Saudi Arabia
Nada O Bamashmous, BDS, MSc, DDENT
study director · Faculty of Dentistry, Department of Pediatric Dentistry, King Abdulaziz University Jeddah, Saudi Arabia
Shatha O Bamashmous, BDS, MSc, PhD
study director · Department of Periodontology, KAU Faculty of Dentistry, Jeddah, Saudi Arabia

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion